z-logo
Premium
Clinical, electrophysiologic, and imaging features of zoster‐associated limb paresis
Author(s) -
Jones Lyell K.,
Haatem Reda,
Watson James C.
Publication year - 2014
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.24141
Subject(s) - medicine , paresis , mononeuropathy , weakness , postherpetic neuralgia , brachial plexopathy , muscle weakness , brachial plexus , electromyography , shingles , complication , peripheral neuropathy , surgery , amyotrophy , anesthesia , atrophy , physical medicine and rehabilitation , neuropathic pain , diabetes mellitus , endocrinology , virus , virology
: Paresis is a long‐recognized complication of herpes zoster, but there has been comparatively little study of zoster‐associated limb paresis (ZALP). Methods : In this study we reviewed 49 Mayo Clinic patients with ZALP. Results : The mean age of onset was 71 years, 67% were men, and the lower limb was affected in 55%. The mean weakness score was 2.0 (0 = normal strength, 4 = plegia). Most patients developed postherpetic neuralgia (PHN, 92% at 1 month and 65% at 3 months), and the average minimum duration of weakness was 193 days. ZALP was caused by radiculopathy (37%), plexopathy (41%), mononeuropathy (14%), and radiculoplexus neuropathy (8%). MRI demonstrated nerve enlargement, T2 signal prolongation, or enhancement in a majority (64%) of affected plexi and peripheral nerves. Conclusions : ZALP is associated with considerable weakness. It typically lasts at least several months, localizes to plexus or peripheral nerve in 63%, and is associated with high rates of PHN. Muscle Nerve 50:177–185, 2014

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom